These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19747823)

  • 1. Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors.
    Salzameda NT; Barbieri JT; Janda KD
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5848-50. PubMed ID: 19747823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.
    Schmidt JJ; Stafford RG
    Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buforin I, a natural peptide, inhibits botulinum neurotoxin B activity in vitro.
    Garcia GE; Moorad DR; Gordon RK
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S19-22. PubMed ID: 10594894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease.
    Sukonpan C; Oost T; Goodnough M; Tepp W; Johnson EA; Rich DH
    J Pept Res; 2004 Feb; 63(2):181-93. PubMed ID: 15009541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease.
    Oost T; Sukonpan C; Brewer M; Goodnough M; Tepp W; Johnson EA; Rich DH
    Biopolymers; 2003; 71(6):602-19. PubMed ID: 14991672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F.
    Schmidt JJ; Stafford RG; Millard CB
    Anal Biochem; 2001 Sep; 296(1):130-7. PubMed ID: 11520041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ; Stafford RG
    Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of phosphoramidon and three synthetic phosphonates for inhibition of botulinum neurotoxin B catalytic activity.
    Adler M; Nicholson JD; Starks DF; Kane CT; Cornille F; Hackley BE
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S5-S11. PubMed ID: 10594892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
    Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir DT; Bavari S; Bowlin TL
    J Med Chem; 2010 Mar; 53(5):2264-76. PubMed ID: 20155918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of an expression system for a synaptobrevin fragment to monitor cleavage by botulinum neurotoxin B.
    Nowakowski JL; Courtney BC; Bing QA; Adler M
    J Protein Chem; 1998 Jul; 17(5):453-62. PubMed ID: 9717740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid microplate assay for monitoring botulinum neurotoxin B catalytic activity.
    Keller JE; Nowakowski JL; Filbert MG; Adler M
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S13-7. PubMed ID: 10594893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates.
    Perpetuo EA; Juliano L; Juliano MA; Fratelli F; Prado SM; Pimenta DC; Lebrun I
    Protein Pept Lett; 2008; 15(10):1100-6. PubMed ID: 19075822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity.
    Adler M; Nicholson JD; Cornille F; Hackley BE
    FEBS Lett; 1998 Jun; 429(3):234-8. PubMed ID: 9662424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity.
    Gilmore MA; Williams D; Okawa Y; Holguin B; James NG; Ross JA; Roger Aoki K; Jameson DM; Steward LE
    Anal Biochem; 2011 Jun; 413(1):36-42. PubMed ID: 21300022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple, rapid and sensitive FRET assay for botulinum neurotoxin serotype B detection.
    Guo J; Xu C; Li X; Chen S
    PLoS One; 2014; 9(12):e114124. PubMed ID: 25437190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.
    Šilhár P; Alakurtti S; Čapková K; Xiaochuan F; Shoemaker CB; Yli-Kauhaluoma J; Janda KD
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2229-31. PubMed ID: 21421315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A graphene oxide based fluorescence resonance energy transfer (FRET) biosensor for ultrasensitive detection of botulinum neurotoxin A (BoNT/A) enzymatic activity.
    Shi J; Guo J; Bai G; Chan C; Liu X; Ye W; Hao J; Chen S; Yang M
    Biosens Bioelectron; 2015 Mar; 65():238-44. PubMed ID: 25461164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
    Foran P; Shone CC; Dolly JO
    Biochemistry; 1994 Dec; 33(51):15365-74. PubMed ID: 7803399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity.
    Blommaert A; Turcaud S; Anne C; Roques BP
    Bioorg Med Chem; 2004 Jun; 12(11):3055-62. PubMed ID: 15142564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
    Cornille F; Roques BP
    J Soc Biol; 1999; 193(6):509-16. PubMed ID: 10783709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.